Assessment of peripheral tolerance in anti-CD4 treated C57BL/6 mouse heart transplants recipients

Transplant Immunology

Volumn 7, Issue 1, 1999, Pages 37-44

  Han, W R ^a   Murray Segal, L J ^a   Mottram, P L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; MONOCLONAL ANTIBODY;

ALLOGRAFT; ALLOIMMUNITY; ANIMAL EXPERIMENT; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY; CELL MEDIATED LYMPHOLYSIS; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOCOMPATIBILITY COMPLEX; ISOGRAFT; JUGULAR VEIN; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN GRAFT; SPLEEN CELL; VASCULAR DISEASE;

EID: 0032921103     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(99)80017-3     Document Type: Article

References (49)

1. Charlton B, Auchincloss HJ, Fathman CG. Mechanisms of transplantation tolerance. Ann Rev Immunol. 12:1994;707-734.
2. Mottram PL, Wheelahan J, Mirisklavos A, Clunie GJ, McKenzie IF. Prolongation of murine cardiac allografts following treatment of graft recipients with monoclonal anti-L3T4 and Ly-2 antibodies. Transplant Proc. 19:1987;582-585.
3. Cobbold SP, Adams E, Marshall SE, Davies JD, Waldmann H. Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CD8. Immunol Rev. 149:1996;5-33.
4. Herbert J, Roser B. Strategies of monoclonal antibody therapy that induce permanent tolerance of organ transplants. Transplantation. 46:1988;1285-1345.
5. Cobbold SP, Qin S, Leong LYW, Martin G, Waldmann H. Reprogramming the immune system for peripheral tolerance with CD4 and CD8 monoclonal antibodies. Immunol Rev. 129:1992;164-210.
6. Chen Z, Cobbold SP, Metcalfe S, Waldmann H. Tolerance in the mouse to major histocompatibility complex-mismatched heart allografts and to rat xenografts, using monoclonal antibodies to CD4 and CD8. Eur J Immunol. 22:1992;805-810.
7. Pearson TC, Darby CR, Bushell AR, West LJ, Morris PJ, Wood KJ. The assessment of transplantation tolerance induced by anti-CD4 monoclonal antibody in the murine model. Transplantation. 55:1993;361-367.
8. Räisänen-Sokolowski A, Glysing-Jensen T, Mottram P, Russell M. Sustained anti-CD4/CD8 blocks inflammatory activation and intimal thickening in mouse heart allografts. Arterioscl Thromb Vasc Biol. 17:1997;2115-2122.
9. Räisänen-Sokolowski A, Mottram P, Glysing-Jensen T, Satoskar A, Russell M. Heart transplants in interferon-gamma, interleukin 4 and interleukin 10 knockout mice: Recipient environment alters graft rejection. J Clin Invest. 100:1997;2449-2456.
10. Dialynas DP, Quan ZS, Wall KA, et al. Characterisation of the murine T cell surface molecule, designated L3T4, identified by the monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J Immunol. 131:1983;2445-2451.
11. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice. The role of H- 2D, H-2K, and non-H-2 antigens in rejection. Transplantation. 16:1973;343-350.
12. Barrett LV, Kirkman R. An Alternative Heterotopic Cardiac Transplantation Technique in Mice. Harvard University teaching video 1989.
13. Mottram PL, Smith JA, Mason A, Mirisklavos A, Dumble LJ, Clunie GJ. Electrocardiographic monitoring of cardiac transplants in mice. Cardiovasc Res. 22:1988;315-321.
14. Billingham R, Medewar P. Teachnique of free skin grafting in mammals. J Exp Biol. 28:1951;385-402.
15. Adams DH, Tilney NL, Collins JJ, Karnovsky MJ. Experimental graft arteriosclerosis. I. The Lewis-to-F-344 allograft model. Transplantation. 53:1992;1115-1119.
16. Brown M, Engelman L, Frans J, Hill M, Jennich R, Toporek J. BMDP Statistical Software. 1983;University of California Press, Berkeley, CA. 1983 printing with additions.
17. Mottram P, Räisänen-Sokolowski A, Glysing-Jensen T, Stein-Oakley A, Russell M. Cardiac allografts from interleukin 4 (IL-4) knockout recipients: Assessment of transplant arteriosclerosis and peripheral tolerance. J Immunol. 161:1998;602-609.
18. Mottram PL, Han WR, Purcell LJ, McKenzie IF, Hancock WW. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy. Transplantation. 59:1995;559-565.
19. Davies JD, Cobbold SP, Waldmann H. Strain variation in susceptibility to monoclonal antibody-induced transplantation tolerance. Transplantation. 63:1997;1570-1573.
20. Orosz C, Wakely E, Bergese S, et al. Prevention of murine cardiac allograft rejection with gallium nitrate. Comparison with anti-CD4 monoclonal antibody. Transplantation. 61:1996;783-791.
21. Han W, Mottram P, McKenzie I. Comparison of CD4 depleting and non-depleting monoclonal antibodies in the mouse heart allograft model. Transplant Proc. 25:1993;2933-2934.
22. Pearson TC, Madsen JC, Larsen CP, Morris PJ, Wood KJ. Induction of tolerance in adults using donor antigen anti-CD4 monoclonal antibody. Transplantation. 54:1992;475-483.
23. Hall BM. Cells mediating allograft rejection. Transplantation. 51:1991;1141-1151.
24. Steinmuller D, Wakely E, Landas S. Evidence that epidermal alloantigen EPA-1 is an immunogen for murine heart as well as skin allograft rejection. Transplantation. 51:1991;459-463.
25. Clarke Forbes R, Gomersall M, Darden A, Guttmann R. Multiple patterns of MHC class II antigen expression on cellular constituents of rat heart grafts. Lack of correlation with graft survival, but strong correlation with vasculitis. Transplantation. 51:1991;942-948.
26. Larsen CP, Morris PJ, Austyn JM. Migration of dendritic leukocytes from cardiac allografts into host spleens. J Exp Med. 171:1990;307.
27. Larsen C, Steinman R, Witmer-Pack M, Hankins D, Morris P, Austyn J. Migration and maturation of Langerhans cells in skin transplants and explants. J Exp Med. 166:1990;1654-1667.
28. Sykes M. Chimerism and central tolerance. Curr Opin Immunol. 8:1996;694-703.
29. Darby CR, Morris PJ, Wood KJ. Evidence that long-term cardiac allograft survival induced by anti-CD4 monoclonal antibody does not require depletion of CD4+ T cells. Transplantation. 54:1992;483-490.
30. Pearson TC, Alexander DZ, Winn KJ, Linsley PS, Lowry RP, Larsen CP. Transplantation tolerance induced by CTLA4-Ig. Transplantation. 57:1994;1701-1706.
31. Nickerson P, Steurer W, Steiger J, Zheng X, Steele A, Strom T. Cytokines and Th1/Th2 paradigm in transplantation. Curr Opin Immunol. 6:1994;757-764.
32. Scully R, Qin S, Cobbold S, Waldmann H. Mechanisms in CD4 antibody-mediated transplantation tolerance: kinetics of induction, antigen dependency and role of regulatory T cells. Eur J Immunol. 24:1994;2383-2392.
33. Davies JD, Martin G, Phillips J, Marshall SD, Cobbold SP, Waldman H. T cell regulation in adult transplantation tolerance. J Immunol. 157:1996;529-533.
34. Russell PS, Chase CM, Winn HJ, Colvin RB. Coronary atherosclerosis in transplanted mouse hearts. I. Time course and immunogenetic and immunopathological considerations. Am J Pathol. 144:1994;260-274.
35. Russell ME, Utans U, Wallace AF, et al. Identification and upregulation of galactose/N-acetylgalactosamine macrophage lectin in rat cardiac allografts with arteriosclerosis. J Clin Invest. 94:1994;722-730.
36. Larsen C, Elwood E, Alexander D, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature. 381:1996;434-438.
37. Larsen CP, Alexander DZ, Hollenbaugh D, et al. CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway. Transplantation. 61:1996;4-9.
38. Lakkis F, Konieczny B, Saleem S, et al. Blocking the CD28-B7 T cell costimulation pathway induced long term cardiac allograft acceptance in the absence of IL-4. J Immunol. 158:1997;2443-2448.
39. Sun H, Subbotin V, Chen C, et al. Prevention of chronic rejection in mouse aortic allografts by combined treatment with CLTA4-Ig and anti-CD40 ligand monoclonal antibody. Transplantation. 64:1998;1838-1843.
40. Hullet D, Geraphty J, Stoltenberg R, Sollinger H. The impact of acute rejection on the development of intimal hyperplasia associated with chronic rejection. Transplantation. 64:1998;1842-1846.
41. Tilney NL, Whitley WD, Tullius SG, et al. Serial analysis of cytokines, adhesion molecule expression, and humoral responses during development of chronic kidney allograft rejection in a new rat model. Transplant Proc. 25:1993;861-862.
42. Sharma V, Bologa R, Xu G-P, et al. Intragraft TGF-b1 mRNA: a correlate of interstitial fibrosis and chronic allograft nephropathy. Kidney Int. 49:1996;1297-1303.
43. Roberts A, Sporn M. Physiological actions and clinical applications of transforming growth factor b (TGF-b). Growth Factors. 8:1993;1.
44. Border W, Nobel N. Transforming growth factor-b in tissue fibrosis. N Engl J Med. 331:1994;1286.
45. Laine J, Etelaemaeki P, Holmberg C, Dunkel L. Apoptotic cell death in human chronic renal allograft rejection. Transplantation. 63:1997;101-105.
46. Larsen C, Alexander D, Hendrix R, Ritchie S, Pearson T. Fas-mediated cytotoxicity: an immunoeffector of immunoregulatory pathway in T cell mediated immune responses? Transplantation. 60:1995;221-224.
47. Sharma V, Bologa R, Li B, et al. Molecular executors of cell death-differential intrarenal expression of Fas ligand, Fas, granzyme B and perforin during acute and/or chronic rejection of human renal allografts. Transplantation. 62:1996;1860-1866.
48. Davies JD, Leong YW, Mellor A, Cobbold SP, Waldmann H. T cell suppression in transplantation tolerance through linked recognition. J Immunol. 156:1996;3602-3607.
49. Matzinger P. Tolerance, danger and the extended family. Ann Rev Immunology. 12:1994;991-1045.